American Urological Fined $18.5 Mil. For False Ads In FTC Settlement
This article was originally published in The Tan Sheet
Executive Summary
American Urological Corp. and principal David Brady agree to a fine of $18.5 mil., satisfied by more than $2 mil. in frozen assets, to settle FTC charges that the firm misrepresented in ads the effectiveness of dietary supplements claiming to treat impotence.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning